Officials with the Nebraska Medical Center are treating Ebola virus patient Ashoka Mukpo with an experimental drug, Brincidofovir.
“After looking at the data on this drug, collaborating with the CDC and FDA and speaking with the patient and his family, we decided this was currently our best option for treatment,” said Phil Smith, M.D., medical director of the Biocontainment Unit. “Every patient is somewhat different, and we believe Brincidofovir is the best choice.” Doctors are looking at other options for treatment as well.
Mukpo’s father Dr. Mitchell Levy says Ashoka continue to be nauseated and is experiencing vomiting and diarrhea. He says those are the symptoms expected at this stage of the illness.
Doctors in the unit say things are going smoothly and the staff remains upbeat.
